Top compounds associated with response to CCDC114


Feature Type Standardized
Nominal ANOVA
mRNA 5-FU CTRPv2 pan-cancer AAC -0.088 0.009
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.01
mRNA momelotinib CTRPv2 pan-cancer AAC -0.088 0.01
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.09 0.01
mRNA PD318088 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.12 0.01
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.084 0.01
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC 0.14 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.01
Download CSV